EcoDrugPlus

Matrix Metallopeptidase 12

Ensembl ID : ENSOPRG00000002133
Gene Symbol: MMP12
1 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSOPRG00000001031
Gene Symbol: MMP14
1 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSOPRG00000002679
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSOPRG00000002101
Gene Symbol: MMP3
1 Cross references
492 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSOPRG00000013520
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSOPRG00000014506
Gene Symbol: MMP9
1 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSOPRG00000012124
Gene Symbol: MTOR
1 Cross references
214 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSOPRG00000016061
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSOPRG00000002890
Gene Symbol: METAP2
1 Cross references
214 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSOPRG00000015665
Gene Symbol: MAPT
1 Cross references
255 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSOPRG00000014484
Gene Symbol: MAPK1
3 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSOPRG00000009834
Gene Symbol: MAPK10
1 Cross references
147 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).